RAFFA WEALTH MANAGEMENT, LLC’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.76K Buy
191
+24
+14% +$709 ﹤0.01% 518
2026
Q1
$4.63K Buy
167
+7
+4% +$180 ﹤0.01% 552
2025
Q4
$3.47K Hold
160
﹤0.01% 593
2025
Q3
$2.42K Hold
160
﹤0.01% 661
2025
Q2
$1.8K Hold
160
﹤0.01% 718
2025
Q1
$1.61K Hold
160
﹤0.01% 693
2024
Q4
$1.89K Hold
160
﹤0.01% 682
2024
Q3
$1.85K Hold
160
﹤0.01% 658
2024
Q2
$1.69K Hold
160
﹤0.01% 759
2024
Q1
$1.69K Hold
160
﹤0.01% 750
2023
Q4
$1.8K Hold
160
﹤0.01% 651
2023
Q3
$1.87K Buy
+160
New +$1.81K ﹤0.01% 606

Other funds holding ROIV

RAFFA WEALTH MANAGEMENT, LLC's ROIV Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC increased its Roivant Sciences (ROIV) stake by 14% in Q2 2026, buying an estimated $709 and bringing the position to 191 shares worth $6.76K. The position accounts for ﹤0.01% of the portfolio, ranked #518.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in ROIV in Q3 2023 and has held it in 12 quarters since. 113 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • RAFFA WEALTH MANAGEMENT, LLC held 191 shares of Roivant Sciences worth $6.76K as of Q2 2026.
  • RAFFA WEALTH MANAGEMENT, LLC bought 24 Roivant Sciences shares in Q2 2026, an estimated $709.
  • Roivant Sciences made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #518 holding.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in Roivant Sciences in Q3 2023 and has held it in 12 quarters since.
  • 113 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.